ESSENS – Hyperglycemia Trial
(Blood Sugar)
STUDY AIMS
STUDY POPULATION
TRIAL REGISTRATION
PATIENT VISITS
STUDY END POINTS
RESULTS
COMMITTEE & INVESTIGATORS
EXECUTIVE COMMITTEE
INVESTIGATORS
CENTRAL LAB & CRO
CONTACT
ESSENS-HYPERLIPIDEMIA TRIAL
(Cholesterol)
STUDY AIMS
STUDY POPULATION
TRIAL REGISTRATION
PATIENT VISITS
STUDY END POINTS
RESULTS
COMMITTEE & INVESTIGATORS
EXECUTIVE COMMITTEE
INVESTIGATORS
CENTRAL LAB & CRO
CONTACT
E
valuation
S
eries on
S
afety and
E
fficacy of
N
utritional
S
upplements
ESSENS-HYPERLIPIDEMIA TRIAL
STUDY END POINTS
Primary Study Objectives
To assess the Efficacy and Safety of PreLipid ® by:
Measuring reduction % changes of LDL-C from baseline to the end of supplementation after 3 months and,
Evaluating safety and tolerability by measuring changes in baseline renal function and liver function tests
Secondary Study Objectives
To assess reduction % changes of Triglyceride (TG) levels from baseline to at the end of supplementation after 3 months.
To assess % changes in Blood Sugar profile (FPG, PPG & HbA1c) from baseline to at the end of treatment after 3 months.
